Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
4.420
+0.190 (4.49%)
At close: Oct 9, 2026, 4:00 PM EDT
4.520
+0.100 (2.26%)
After-hours: Oct 9, 2026, 7:51 PM EDT
Fractyl Health Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
100
Market Cap
58.63M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 93.00K | -27.00K | -22.50% |
| Dec 31, 2023 | 120.00K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Xilio Therapeutics | 64.09M |
| Caribou Biosciences | 10.04M |
| Alps Group | 3.74M |
| Connect Biopharma Holdings | 2.95M |
| Alterity Therapeutics | 2.50M |
| Mereo BioPharma Group | 500.00K |
GUTS News
- 7 days ago - Fractyl Health Inc trading halted, news pending - TheFly
- 8 days ago - Shareholders Sue Fractyl (GUTS) Over Weight Loss Drug Claims - TipRanks
- 10 days ago - Robbins LLP is Investigating Allegations that Fractyl Health, Inc. Misled Investors Regarding the Viability and Efficacy of its Revita DMR System - Newsfile Corp
- 15 days ago - Fractyl Health Transcript: EGM 2026 - Transcripts
- 23 days ago - GUTS Stockholders Have Rights – If you Lost Money Investing in Fractyl Health, Inc. Contact Robbins LLP for Information About Recovering Your Losses - Business Wire
- 24 days ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 20, 2026 in Fractyl Health, Inc. Lawsuit - GUTS - GlobeNewsWire
- 25 days ago - Fractyl Health Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - Fractyl Health Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts